Shoujie Huang

3.2k total citations
41 papers, 723 citations indexed

About

Shoujie Huang is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Shoujie Huang has authored 41 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 19 papers in Hepatology and 15 papers in Infectious Diseases. Recurrent topics in Shoujie Huang's work include Hepatitis B Virus Studies (18 papers), Cervical Cancer and HPV Research (17 papers) and Hepatitis Viruses Studies and Epidemiology (17 papers). Shoujie Huang is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Cervical Cancer and HPV Research (17 papers) and Hepatitis Viruses Studies and Epidemiology (17 papers). Shoujie Huang collaborates with scholars based in China, Taiwan and United States. Shoujie Huang's co-authors include Jun Zhang, Ting Wu, Ningshao Xia, Fengcai Zhu, Mun‐Hon Ng, Yingying Su, Han-Min Jiang, Zhongze Wang, Yijun Wang and Xing Ai and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Shoujie Huang

38 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoujie Huang China 17 374 312 304 73 64 41 723
Toni Luise Meister Germany 16 155 0.4× 107 0.3× 465 1.5× 9 0.1× 19 0.3× 49 773
Catharina J. Alberts Netherlands 13 117 0.3× 377 1.2× 113 0.4× 119 1.6× 41 0.6× 27 666
Zizheng Zheng China 18 582 1.6× 846 2.7× 882 2.9× 78 1.1× 177 2.8× 57 1.7k
C. G. Teo United Kingdom 17 418 1.1× 502 1.6× 280 0.9× 21 0.3× 34 0.5× 28 860
Rüçhan Sertöz Türkiye 14 154 0.4× 214 0.7× 280 0.9× 15 0.2× 24 0.4× 54 624
Shuyi He China 12 67 0.2× 185 0.6× 181 0.6× 13 0.2× 29 0.5× 22 344
Robin A. Gutierrez United States 14 784 2.1× 653 2.1× 267 0.9× 11 0.2× 55 0.9× 28 1.0k
H. W. Doerr Germany 12 135 0.4× 251 0.8× 247 0.8× 39 0.5× 81 1.3× 33 582
Graciela Glikmann Argentina 15 171 0.5× 142 0.5× 497 1.6× 53 0.7× 58 0.9× 38 698
G. Zoulek Germany 9 135 0.4× 301 1.0× 90 0.3× 37 0.5× 85 1.3× 17 414

Countries citing papers authored by Shoujie Huang

Since Specialization
Citations

This map shows the geographic impact of Shoujie Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoujie Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoujie Huang more than expected).

Fields of papers citing papers by Shoujie Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoujie Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoujie Huang. The network helps show where Shoujie Huang may publish in the future.

Co-authorship network of co-authors of Shoujie Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shoujie Huang. A scholar is included among the top collaborators of Shoujie Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoujie Huang. Shoujie Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhuang, Chunlan, Lu Chen, Han-Min Jiang, et al.. (2025). Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study. Nature Communications. 16(1). 1699–1699. 1 indexed citations
2.
Zhuang, Chunlan, Yue Huang, Fan Liu, et al.. (2025). Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody. Cancer Epidemiology Biomarkers & Prevention. 34(12). 2239–2246.
3.
Chu, Kai, Xiaohui Liu, Qi Chen, et al.. (2025). A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years. npj Vaccines. 10(1). 50–50. 2 indexed citations
4.
Chen, Lu, Chunlan Zhuang, Yingying Su, et al.. (2024). Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus. npj Vaccines. 9(1). 245–245.
5.
Su, Yingying, Xinhua Jia, Yufei Li, et al.. (2024). Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18–45 years. Human Vaccines & Immunotherapeutics. 20(1). 2334474–2334474. 6 indexed citations
6.
Zhuang, Chunlan, Xiaowen Hu, Qi Chen, et al.. (2023). Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial. Emerging Microbes & Infections. 12(1). 2185456–2185456. 12 indexed citations
7.
8.
Zhuang, Chunlan, Xiaohui Liu, Qi Chen, et al.. (2022). Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective. Frontiers in Microbiology. 13. 828806–828806. 23 indexed citations
9.
Wen, Guiping, Linling He, Zimin Tang, et al.. (2020). Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans. Nature Communications. 11(1). 3971–3971. 27 indexed citations
10.
Chen, Qi, Hui Zhao, Xingmei Yao, et al.. (2020). Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages. Vaccine. 38(39). 6096–6102. 8 indexed citations
11.
Li, Juan, Zhijie Lin, Hui Zhao, et al.. (2020). Immunogenicity of an Escherichia coli -produced bivalent human papillomavirus vaccine under different vaccination intervals. Human Vaccines & Immunotherapeutics. 16(7). 1630–1635. 2 indexed citations
12.
Chen, Zhiping, Shenyu Wang, Huirong Pan, et al.. (2019). Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years. Vaccine. 37(32). 4581–4586. 24 indexed citations
13.
Wei, Feixue, Sheng Wei, Xin Wu, et al.. (2017). Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system. Emerging Microbes & Infections. 6(1). 1–8. 8 indexed citations
14.
Huang, Yue, Lin Wang, Yingying Su, & Shoujie Huang. (2016). Progress in clinical immunology of human papillomavirus vaccines. Zhonghua weishengwuxue he mianyixue zazhi. 36(7). 534–539. 1 indexed citations
15.
Wei, Feixue, Kai Yin, Xin Wu, et al.. (2016). Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study. Emerging Microbes & Infections. 5(1). 1–8. 30 indexed citations
16.
17.
Chen, Shu, Zi Zhou, Feixue Wei, et al.. (2015). Modeling the long-term antibody response of a hepatitis E vaccine. Vaccine. 33(33). 4124–4129. 21 indexed citations
18.
Zhu, Fengcai, Shoujie Huang, Ting Wu, et al.. (2014). Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in China. PLoS ONE. 9(1). e87154–e87154. 47 indexed citations
19.
Hu, Yuemei, Shoujie Huang, Kai Chu, et al.. (2013). Safety of anEscherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine. Human Vaccines & Immunotherapeutics. 10(2). 469–475. 27 indexed citations
20.
Huang, Shoujie, Xiaohui Liu, Jun Zhang, & Mun‐Hon Ng. (2013). Protective immunity against HEV. Current Opinion in Virology. 5. 1–6. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toni Luise Meister Breakdown of academic impact, for papers by Catharina J. Alberts Breakdown of academic impact, for papers by Zizheng Zheng Breakdown of academic impact, for papers by C. G. Teo Breakdown of academic impact, for papers by Rüçhan Sertöz Breakdown of academic impact, for papers by Shuyi He Breakdown of academic impact, for papers by Robin A. Gutierrez Breakdown of academic impact, for papers by H. W. Doerr Breakdown of academic impact, for papers by Graciela Glikmann Breakdown of academic impact, for papers by G. Zoulek
Rankless by CCL
2026